CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company’s Toll-Like Receptor - targeted drug discovery and development programs and provide a general corporate overview at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference taking place April 11-12, 2007 at the Millennium Broadway Hotel in New York City. The presentation will begin at 2:30 p.m. (ET) on Wednesday, April 11, 2007.
